fbpx

PubMed: Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

PubMed: Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

Front Pharmacol. 2022 May 19;13:881617. doi: 10.3389/fphar.2022.881617. eCollection 2022.

ABSTRACT

Cannabidiol (CBD) is a non-psychotomimetic constituent of the Cannabis plant, with potential therapeutic properties for many physical and neuropsychiatric conditions. Isolated CBD has been suggested to have favorable safety and tolerability. Although CBD-related rash is described, few case reports are well documented in the literature, and usually, CBD was used concomitantly with other medications. Thus, we report four women who presented a skin rash after ongoing CBD use. Other causes of these skin rashes were ruled out after conducting an extensive viral and serological detection panel, and three patients had their lesions biopsied. Two patients were re-exposed to the vehicle (MCT) without developing a new skin rash. Therefore, clinicians must be aware of this potential adverse effect of CBD use.

PMID:35662726 | PMC:PMC9161546 | DOI:10.3389/fphar.2022.881617

#CBD #Hemp https://pubmed.ncbi.nlm.nih.gov/35662726/?utm_source=Chrome&utm_medium=rss&utm_campaign=None&utm_content=1jYCQzi_o_qLYr-oQfnMhShgOXkvGma3vcnBGJtrBhuJMOvEVJ&fc=None&ff=20220607065831&v=2.17.6 June 6, 2022 10:00 am

বাংলা简体中文繁體中文EnglishFrançaisDeutschहिन्दीItaliano日本語한국어मराठीPortuguêsਪੰਜਾਬੀРусскийEspañolSvenskaతెలుగుไทยTürkçeУкраїнськаTiếng Việt